


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
